1. Home
  2. FGEN vs KLXE Comparison

FGEN vs KLXE Comparison

Compare FGEN & KLXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • KLXE
  • Stock Information
  • Founded
  • FGEN 1993
  • KLXE 2018
  • Country
  • FGEN United States
  • KLXE United States
  • Employees
  • FGEN N/A
  • KLXE N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • KLXE Oilfield Services/Equipment
  • Sector
  • FGEN Health Care
  • KLXE Energy
  • Exchange
  • FGEN Nasdaq
  • KLXE Nasdaq
  • Market Cap
  • FGEN 33.5M
  • KLXE 35.8M
  • IPO Year
  • FGEN 2014
  • KLXE N/A
  • Fundamental
  • Price
  • FGEN $0.30
  • KLXE $2.23
  • Analyst Decision
  • FGEN Strong Buy
  • KLXE Hold
  • Analyst Count
  • FGEN 1
  • KLXE 1
  • Target Price
  • FGEN $10.00
  • KLXE $4.50
  • AVG Volume (30 Days)
  • FGEN 594.8K
  • KLXE 173.4K
  • Earning Date
  • FGEN 05-12-2025
  • KLXE 05-08-2025
  • Dividend Yield
  • FGEN N/A
  • KLXE N/A
  • EPS Growth
  • FGEN N/A
  • KLXE N/A
  • EPS
  • FGEN N/A
  • KLXE N/A
  • Revenue
  • FGEN $6,996,000.00
  • KLXE $688,600,000.00
  • Revenue This Year
  • FGEN $232.81
  • KLXE $0.22
  • Revenue Next Year
  • FGEN $9.16
  • KLXE $4.89
  • P/E Ratio
  • FGEN N/A
  • KLXE N/A
  • Revenue Growth
  • FGEN N/A
  • KLXE N/A
  • 52 Week Low
  • FGEN $0.18
  • KLXE $1.51
  • 52 Week High
  • FGEN $1.74
  • KLXE $7.66
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 44.76
  • KLXE 49.10
  • Support Level
  • FGEN $0.29
  • KLXE $1.80
  • Resistance Level
  • FGEN $0.32
  • KLXE $2.42
  • Average True Range (ATR)
  • FGEN 0.02
  • KLXE 0.24
  • MACD
  • FGEN 0.00
  • KLXE 0.09
  • Stochastic Oscillator
  • FGEN 26.25
  • KLXE 68.55

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

Share on Social Networks: